Semtech Analyzes SDI for Next-Generation Media Streaming at SMPTE Annual Technical Conference
Oct 24, 2016 12:02 pm UTC| Business
HOLLYWOOD, Oct. 24, 2016 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, will present a paper focusing on serial digital interface (SDI), a versatile and...
Oct 24, 2016 12:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Oct. 24, 2016 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on its proposed phase III clinical program...
Moms Bullying Moms: Survey Finds 80% of Moms Have Been "Mom Shamed," Mostly By Other Moms
Oct 24, 2016 12:01 pm UTC| Business
SAN FRANCISCO, Oct. 24, 2016 -- “Moms bullying moms” is among the most surprising findings of a new survey conducted by mom.life, the app for modern moms. The research, which sought to better understand the far-reaching...
Uranium Resources Announces Receipt of $250,000 Extension Payment
Oct 24, 2016 12:01 pm UTC| Business
CENTENNIAL, Colo., Oct. 24, 2016 -- Uranium Resources, Inc. (URI) (Nasdaq:URRE) (ASX:URI), announced today that it has received the cash extension payment of $250,000 from Laramide Resources Ltd. (Laramide) for...
Aduro Biotech Reports Partial Clinical Hold to Pause Enrollment in LADD Trials
Oct 24, 2016 12:01 pm UTC| Business
--Current Clinical Trial Patients Are Continuing to Receive LADD Treatment-- --Company to Host Conference Call Today at 6 a.m. PT/9 a.m. ET-- BERKELEY, Calif., Oct. 24, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a...
Aduro Biotech Reports Partial Clinical Hold to Pause Enrollment in LADD Trials
Oct 24, 2016 12:01 pm UTC| Business
--Current Clinical Trial Patients Are Continuing to Receive LADD Treatment-- --Company to Host Conference Call Today at 6 a.m. PT/9 a.m. ET-- BERKELEY, Calif., Oct. 24, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a...
Advaxis Announces GOG-0265 12-month Overall Survival Rate of 37.5% in Stage 2
Oct 24, 2016 12:01 pm UTC| Business
Data in 50 patients with recurrent metastatic carcinoma of the cervix demonstrates a 52% increase in 12-month overall survival rate PRINCETON, N.J., Oct. 24, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage...